Status:
COMPLETED
Trial Comparing the Incidence of Steal Syndrome in the Two Types of anTEcubitaL Fossa Arteriovenous fistuLa AVF
Lead Sponsor:
Cambridge University Hospitals NHS Foundation Trust
Conditions:
Arteriovenous Fistulas
Renal Failure, End-Stage
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Background: Arteriovenous fistula (AVF) is a form of vascular access for haemodialysis. An AVF is normally created at the level of the wrist, but occasionally it is created in the elbow when there is...
Detailed Description
Arteriovenous fistulas (AVF) are the safest form of vascular access for long-term haemodialysis in patients with end-stage renal failure. The strategy in creating an AVF in the upper limbs is to start...
Eligibility Criteria
Inclusion
- End stage renal failure Requiring AVF at in the antecubital fossa for haemodialysis
Exclusion
- When the participant has not received the allocated intervention due to anatomical anomaly, technical issue or any other reason
Key Trial Info
Start Date :
February 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2018
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT02297451
Start Date
February 1 2011
End Date
December 1 2018
Last Update
January 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Addenbrooke's Hospital
Cambridge, United Kingdom, CB2 0QQ